<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/762078AC-3195-4911-8A8F-FB4A6C699DE7"><gtr:id>762078AC-3195-4911-8A8F-FB4A6C699DE7</gtr:id><gtr:name>Women at Work International (WAWI)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/762078AC-3195-4911-8A8F-FB4A6C699DE7"><gtr:id>762078AC-3195-4911-8A8F-FB4A6C699DE7</gtr:id><gtr:name>Women at Work International (WAWI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6DC31837-4293-4838-972E-B70F4401FDE0"><gtr:id>6DC31837-4293-4838-972E-B70F4401FDE0</gtr:id><gtr:firstName>Heiner</gtr:firstName><gtr:surname>Grosskurth</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/42CE62AA-63C7-447E-8692-AE40469EF4A2"><gtr:id>42CE62AA-63C7-447E-8692-AE40469EF4A2</gtr:id><gtr:firstName>Anatoli</gtr:firstName><gtr:surname>Kamali</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6FACDC7D-F7E9-423A-B957-C179D2F25D94"><gtr:id>6FACDC7D-F7E9-423A-B957-C179D2F25D94</gtr:id><gtr:firstName>Judith</gtr:firstName><gtr:surname>Vandepitte</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U950088496"><gtr:id>DB6520A8-CB5A-4185-BCF5-00D7068A04E5</gtr:id><gtr:title>STI Research Programme / Good Health for Women Project</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U950088496</gtr:grantReference><gtr:abstractText>The HIV epidemic in Uganda has been declining throughout the 1990s, but rates of infection have been on the increase in recent years. Renewed efforts are needed to consolidate past successes in the control of the epidemic. Interventions among groups at high risk of HIV transmission are particularly important but are not yet broadly available in Uganda. Our research will establish the frequency of existing and new HIV infection and of other sexually transmitted infections (STIs) among women engaged in sex for money, and help to understand which social and cultural factors contribute to the problem. We will then develop and evalaute interventions to reduce HIV transmission to and from this group. We will also use the opportunity to address a number of pending research questions with respect to HIV and AIDS, for example whether the medicines currently used to treat STIs are still effective in Uganda. An important aspect of the project is research to determine whether this study population is suitable for participation in future trials of new vaginal microbicides against HIV infection. This population could potentially benefit strongly from such products if found effective.</gtr:abstractText><gtr:technicalSummary>The prevalence of HIV infection in Uganda has been declining throughout the 1990s, but has been on the increase in recent years, at least in some sub-populations. Interventions against a renewed surge of the epidemic are needed both for the general population and for high risk groups. Only very few targeted interventions are in place for high risk behaviour groups in Uganda. The project will establish the prevalence, incidence and contributing societal factors of HIV infection and other sexually transmitted infections (STIs) among women engaged in commercial sexual services in Kampala, and will develop and operational evaluate interventions to reduce HIV transmission to and from this group. We use the opportunity to also address a number of pending research questions with respect to HIV and AIDS, e.g. whether the hypothesis is correct that Haemophilus ducreyi has largely disappeared from the spectrum of microbial agents associated with genital ulcers in East Africa; whether the syndromic treatment algorithms for STIs currently in use in Uganda are still effective or require adjustments, whether there are associations between intravaginal practices (use of herbs etc) and HIV acquisition, and whether women from the study population represent a suitable group for conducting future vaginal microbicide trials. The project recruits an open cohort of 1000 women engaged in high risk sexual behaviour from bars, guesthouses and other entertainment facilities in Kampala. Women are followed up at 3-monthly intervals and whenever they are ill. At baseline and at each subsequent visit a questionnaire on demographic data and risk factors is applied, a genital examination is performed and genital and blood specimens are collected. The specimens are used to screen for common sexually transmitted infections (STIs), including HIV infection, syphilis, chlamydia infection, gonorrhoea, mycoplasma genitalis infection, trichomoniasis, bacterial vaginosis, candidiasis, and genital ulcers due to chancroid, syphilis, herpes simplex virus infection and lymphogranuloma venereum. Treatment for STIs is provided initially according to national guidelines and otherwise based on laboratory results. Women and their children are also treated for other common ailments. Women requiring antiretroviral treatment receive it from a collaborating hospital.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>4201998</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>LSHTM</gtr:description><gtr:id>32825C74-8D17-404C-9B53-7B1500EBB81B</gtr:id><gtr:impact>All capacity building requirements for setting up future microbicide clinical trials are accomplished: all staff were trained on Good Clinical Practice, an internal and external monitoring system has been set up and a community advisory board is in place. The full cohort has been set up and been followed up for a year. Data analysis has been completed. The baseline reustls have been published. The writing up of the follow up results of the cohort is currently underway.</gtr:impact><gtr:outcomeId>FEFA4C30882-1</gtr:outcomeId><gtr:partnerContribution>The LSHTM has succeeded to get a grant from EDCTP (European and Developing Countries Clinical Trials Partnership) for the implementation of a microbicide feasibility study embedded into the Good Health for Women Project. Scientific and technical input was given for the setting up of the study and assistance for the statistical analyses of the data.</gtr:partnerContribution><gtr:piContribution>The existing clinic and office facilities, the established laboratory and data management capacities were used for this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Women at Work International (WAWI)</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>WAWI</gtr:description><gtr:id>20BE884A-0972-465B-BF5A-F2FE594EFBED</gtr:id><gtr:impact>The recruitment of the cohort (1027 women) was successfull within one year. The attendance rate into the cohort remains high (75-80%). This is greatly thanks to the good communication between WAWI and the study population.</gtr:impact><gtr:outcomeId>6F20821C483-1</gtr:outcomeId><gtr:partnerContribution>Access given to the study population</gtr:partnerContribution><gtr:piContribution>Study population is given access to the care and activities delivered by the project clinic, such as: HIV testing and counseling, STI screening, risk reducing counselling, condom promotion, general care.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Pepfar-CDC Uganda</gtr:description><gtr:id>65249E1A-895D-498B-83B0-5040B4CF1406</gtr:id><gtr:impact>The activities for the FSW have been maintained: all women are invited at the clinic for 6-monthly visits; they receive VCT, screening and management for STIs, family planning, antenatal care ; screening and counseling for alcohol abuse, risk reduction counseling, counseling on positive living; counseling for uptake and adherence to ART. General care is offered at any time for women and children under 5. 
One day per week, regular male partners of the enrolled FSW are invited at the clinic where by receive similar services (incl referral for male circumcision)
Condoms are provided at selected bars/lodges where FSW tend to find and serve their clients</gtr:impact><gtr:outcomeId>gULf1UJCCcE-1</gtr:outcomeId><gtr:partnerContribution>PEPFAR funding is provided through CDC Uganda and covers most of the salaries of the GHWP staff, the costs for running all clinic and community activities (including consumables, running costs, treatment)</gtr:partnerContribution><gtr:piContribution>The GHWP managed to get PEPFAR funding for 5 years to maintain and expand the existing clinic and community activities for FSW and their male partners in Kampala. The aim of the Pepfar programme is to implement enhanced HIV prevention activities for this target population and to start with Antiretroviral therapy (ART) at the GHWP site in Kampala.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>outcomes</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8ADEB7ED-DAA6-45A2-8D93-9A1C52C39C9A</gtr:id><gtr:impact>Important preliminary study outcomes are regularly communicated to the members of the Community Advisory Board which also represent the study participants

Improved understanding and appreciation for the research done. Booster for the study participants to stay in the project</gtr:impact><gtr:outcomeId>SqPG5Hi5RL9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>219615</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PEPFAR Program Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>United States President's Emergency Plan for AIDS Relief (PEPFAR)</gtr:fundingOrg><gtr:id>B97A0451-42AC-4411-9947-DD4852AF4966</gtr:id><gtr:outcomeId>FkMz4a59nzp0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>786000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>PEPFAR program grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>United States President's Emergency Plan for AIDS Relief (PEPFAR)</gtr:fundingOrg><gtr:id>0F385972-B479-4106-B815-587F46F81747</gtr:id><gtr:outcomeId>qmUpYFrjvfo</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NG treatment</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>B735DEC9-BFE5-4806-95B0-FA11D8D79CCF</gtr:id><gtr:impact>Our survey on the antimicrobial resistance pattern of N. gonorrhoeae found a resistance of 74% to ciprofloxacin which was the recommended treatment. Our findings have led to changes in the national STI guidelines, recommending cefixim as better treatment</gtr:impact><gtr:outcomeId>BGk2yUo4xE2</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>STI guidelines</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>B98B79AC-F1EC-4EB9-9EA5-9E8DAFE9663F</gtr:id><gtr:impact>Our baseline results helped convincing the Uganda National STI Programme (Ministry of Health) for the need to review and update National Guidelines for the Management of Sexually Transmitted Infections in Uganda. With our help, new STI guidelines have been in place since end of 2010</gtr:impact><gtr:outcomeId>CDB588F12CD</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A GCP compliant datamanagement system was set up.</gtr:description><gtr:id>43426CB7-A2AB-4C41-8783-C5B9D263EC62</gtr:id><gtr:impact>Timely consistent results available

Timely data analysis resulting so far in 9 publications and several others in preparation</gtr:impact><gtr:outcomeId>F1F2D5324FB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Database GHWP</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>91FAB445-9F4B-4ED9-94FD-0A19B413FDBE</gtr:id><gtr:title>Clinical characteristics associated with Mycoplasma genitalium infection among women at high risk of HIV and other STI in Uganda.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f897473d58ac2c3138f8a4905bb83c79"><gtr:id>f897473d58ac2c3138f8a4905bb83c79</gtr:id><gtr:otherNames>Vandepitte J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>pm_14955_25_22592838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF648E0A-9F49-4CC8-BB67-C4516048C988</gtr:id><gtr:title>HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f897473d58ac2c3138f8a4905bb83c79"><gtr:id>f897473d58ac2c3138f8a4905bb83c79</gtr:id><gtr:otherNames>Vandepitte J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>KRpZyRH2kH6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51CFF6DD-4E26-49FA-8F4A-AECD9D027F03</gtr:id><gtr:title>Gender inequity in the lives of women involved in sex work in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>Journal of the International AIDS Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a577aeef15bb5101a57680809db9eb5"><gtr:id>6a577aeef15bb5101a57680809db9eb5</gtr:id><gtr:otherNames>Mbonye M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1758-2652</gtr:issn><gtr:outcomeId>pm_14955_25_22713353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59E227B0-621A-436C-9364-A90DBDD8D793</gtr:id><gtr:title>Parenting and money making: sex work and women's choices in urban Uganda. Wagadu</gtr:title><gtr:parentPublicationTitle>Wagadu</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5109ad8f89329e44c32cb048a2f07757"><gtr:id>5109ad8f89329e44c32cb048a2f07757</gtr:id><gtr:otherNames>Zalwango Flavia</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>UYHArxNirV7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54C4C5B1-A645-433B-8AB4-9F7FF2B802C2</gtr:id><gtr:title>HIV type 1 subtype distribution, multiple infections, sexual networks, and partnership histories in female sex workers in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d65a9eea965e9c3dad2ff04c4f72830d"><gtr:id>d65a9eea965e9c3dad2ff04c4f72830d</gtr:id><gtr:otherNames>Ssemwanga D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>GfTp2k2V5iR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7240BE54-B6EC-42C4-93AE-8F230B408DE1</gtr:id><gtr:title>Transmitted antiretroviral drug resistance among drug-naive female sex workers with recent infection in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d65a9eea965e9c3dad2ff04c4f72830d"><gtr:id>d65a9eea965e9c3dad2ff04c4f72830d</gtr:id><gtr:otherNames>Ssemwanga D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_14955_25_22544200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CB89C3B-1687-45E8-8764-D482846559E2</gtr:id><gtr:title>Condom use among female sex workers in Uganda.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ee31969fa3bcacc742867f5fe98f4f7"><gtr:id>8ee31969fa3bcacc742867f5fe98f4f7</gtr:id><gtr:otherNames>Bukenya J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn><gtr:outcomeId>C73kWdMttcF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77BFF587-AB0A-422E-9075-DF910DBC04A8</gtr:id><gtr:title>Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f897473d58ac2c3138f8a4905bb83c79"><gtr:id>f897473d58ac2c3138f8a4905bb83c79</gtr:id><gtr:otherNames>Vandepitte J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>AB9cGXgwK5f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA33494E-5EE4-4448-9DFB-AF7F05A49709</gtr:id><gtr:title>Alcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f897473d58ac2c3138f8a4905bb83c79"><gtr:id>f897473d58ac2c3138f8a4905bb83c79</gtr:id><gtr:otherNames>Vandepitte J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>pm_14955_25_23075920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9804D77-CF23-44CA-AB47-1E04DAEA74EA</gtr:id><gtr:title>Vaginal practices diary: development of a pictorial data collection tool for sensitive behavioral data.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>pm_14955_25_22801344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10449348-A5D6-473C-B3E3-236889FA26A0</gtr:id><gtr:title>Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f897473d58ac2c3138f8a4905bb83c79"><gtr:id>f897473d58ac2c3138f8a4905bb83c79</gtr:id><gtr:otherNames>Vandepitte J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>JkYqEL3SyJ3</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U950088496</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>